Consensus Abbott Laboratories Deutsche Boerse AG

Stocks

ABL0

CA0028221046

Medical Equipment, Supplies & Distribution

Delayed Deutsche Boerse AG 07:50:13 07/10/2026 BST			5-day change	1st Jan Change
10.70 ^EUR	-1.83%		-1.83%	-20.15%

01:14pm	Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target	MT
10-05	Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities	CI

f6ff22f3447cfec81f3.0g3WwBh-4opbpxCiSTtQCxtPrJ-sFvCM-XLFp9Gz5eQ.hm7nkFo42uQQ5GjYPXIoZGsinM7NXLXpiivolJf7loWZT5PzdR2twALFIA~13985ce074e62de677bb17e224f7dac6

Analysts' recommendations: Abbott Laboratories

01:14pm	Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target	MT
10-05	Evercore ISI Adjusts Price Target on Abbott Laboratories to $124 From $120, Keeps Outperform Rating	MT
10-02	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
10-02	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
10-02	Analyst recommendations: Airbnb, Hewlett Packard Enterprise, Fair Isaac, Nike…
08-21	TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating	MT
08-13	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
08-13	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT
07-28	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
07-28	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
07-23	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
07-22	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
07-17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
07-17	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT
07-17	Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating	MT
07-17	BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating	MT
07-17	Citigroup Adjusts Price Target on Abbott Laboratories to $112 From $108, Maintains Buy Rating	MT
07-17	Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating	MT
07-17	Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating	MT
07-16	Wells Fargo Raises Abbott Laboratories Price Target to $112 From $109	MT
07-06	Evercore ISI Adjusts Abbott Laboratories Price Target to $112 From $120	MT
07-01	Baird Initiates Abbott Laboratories at Outperform With $121 Price Target	MT
06-12	BofA Adjusts Price Target on Abbott Laboratories to $102 From $120	MT
05-27	Goldman Sachs Adjusts Price Target on Abbott Laboratories to $113 From $121, Maintains Buy Rating	MT
05-05	Abbott Laboratories Pick of the Week at Smart Insider Following CFO Stock Purchase	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+22.98%
	MEDTRONIC PLC					+19.92%
	STRYKER CORPORATION					+31.62%
	ESSILORLUXOTTICA					+54.94%
	CENCORA, INC.					+16.71%
	HOYA CORPORATION					+19.37%
	BECTON, DICKINSON AND COMPANY					+7.64%
	IDEXX LABORATORIES, INC.					+36.07%
	DEXCOM, INC.					+15.4%
	Average					+24.96%
	Weighted average by Cap.					+25.81%